BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Amedica Corporation Announces Poster Presentation Highlighting Benefits of Silicon Nitride Biomaterial at the 2012 North American Spine Society Annual Meeting


10/23/2012 12:17:58 PM

SALT LAKE CITY, Oct. 23, 2012 /PRNewswire/ -- AMEDICA Corporation, a spinal and reconstructive medical device manufacturer, is pleased to announce that Alpesh Patel, M.D., Associate Professor in the Division of Spine Surgery at the Loyola University Chicago Stritch School of Medicine, will present a poster at the North American Spine Society (NASS) Annual Meeting that illustrates the significant advantages of Silicon Nitride (Si3N4) for use in interbody fusion devices compared to (PEEK) and titanium.

The ePoster (#P82), "Decreased Bacterial Count and BioFilm Formation Associated with Silicon Nitride (Si3N4) Materials Used in Interbody Fusion Cages (IBF) Compared to Titanium and Polyetheretherketone (PEEK)," reports on recently published peer-reviewed studies conducted at Brown University that demonstrated Silicon Nitride's decreased vulnerability to bacterial colonization and biofilm formation in comparison with PEEK and titanium. These attributes may contribute significantly to achieving optimal patient outcomes in clinical applications.

AMEDICA is also hosting a Surgeon Educational Symposium at the conference. Bryan McEntire, AMEDICA's Chief Technology Officer, will provide an overview of the published results of the studies conducted at Brown University, and the company's expansion of biomaterial claims for its FDA 510(k)-cleared Valeo® Interbody Fusion Devices. Two leading spine surgeons, Grant Skidmore, M.D. and Mark Crawford, M.D. will also present patient case studies illustrating the use and efficacy of AMEDICA's Silicon Nitride Interbody Fusion Devices to treat patients suffering from back pain requiring spinal fusion surgery. The symposium will be held on Wednesday, October 24th at 5:30 p.m. CDT at the Adolphus Hotel Century Room, 1321 Commerce Street, Dallas. The Symposium is open to all NASS attendees.

"Spine surgeons are increasingly recognizing the value and benefits of Silicon Nitride for interbody fusion. Material matters and we have scientific, peer-reviewed results that prove Silicon Nitride's ability to promote bone on-growth and minimize patient exposure to infection risk while increasing the potential for fusion in comparison to PEEK and titanium," said Bryan McEntire. "Dr. Skidmore and Dr. Crawford use Silicon Nitride Interbody Fusion Devices to treat patients and truly understand the vast benefits of our technology. Their clinical discussions at our Symposium will help inform other spine specialists about the ability of Silicon Nitride to improve patient care and outcomes."

For additional information or to arrange interviews, please visit AMEDICA at NASS (booth #1638) or visit www.Amedica.com.

About AMEDICA Corporation:

AMEDICA is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications including silicon nitride ceramic technologies. The company's platform technologies represent a new standard for implants and biologics based on superior performance, safety and efficacy. AMEDICA is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. AMEDICA Corporation is based in Salt Lake City, UT.

Media Contact
Stacey Holifield / Stacy Nartker
Schwartz MSL
(781) 684-0770
amedica@schwartzmsl.com

SOURCE AMEDICA Corporation


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->